Functional Brands Acquires Alchemy for $142.9 Million

Health
Health
Definitive Agreement
Definitive Agreement

Show Chart?

Load external content from TradingView!

*You can change or withdraw your consent at any time in the footer under Cookies.

Functional Brands to Acquire Gold-Backed Blockchain Platform Alchemy for $142.9 Million

Lake Oswego, OR - Functional Brands Inc. (NASDAQ: MEHA) has announced the execution of a definitive agreement to acquire assets from BullionFX, including its Alchemy technology platform, in an all-stock transaction valued at $142.9 million. The deal has received unanimous approval from the boards of directors of both companies.

The acquisition aims to integrate a gold-backed blockchain settlement layer and decentralized finance (DeFi) ecosystem into Functional Brands' existing business portfolio. This strategic move is designed to provide institutional and retail users with a platform that generates yields on physical gold positions, a feature management highlights as a significant advantage over traditional gold exchange-traded funds.

Transaction Details

  • Transaction Value: $142.9 million in an all-stock asset acquisition.
  • Platform Capability: A vertically integrated, gold-backed DeFi ecosystem for retail, institutional, and blockchain markets.
  • Strategic Goal: To bridge traditional and decentralized financial products, offering stablecoin-like utility with physical gold backing.

Management emphasized that this acquisition positions Functional Brands to become a consolidation vehicle in the tokenized real-world-asset sector. The company plans to utilize its publicly listed status to further commercialize this technology and expand its market reach into both traditional finance and blockchain ecosystems.

About Functional Brands Inc.

Our company operates in the nutraceutical supplement industry. We are a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, mental clarity & focus, sleep, prenatal and urinary. Our end markets focus on end-consumers through different channels that include pharmacies, US wholesalers, international distributors and direct-to-consumers sales. Our products are sold over the counter, and consumers do not need a prescription to purchase our products. Our products are not approved by the FDA. Our company also operates in the hemp industry as a retailer of hemp derived products in categories such as capsules, cigarettes, gummies, and tinctures with a commercial end market, and end-consumers.

View Company Details

More MEHA News

SPAC IPO Calendar
SPAC IPO Events
Scroll to Top